Developing standards of care for HIV prevention research in developing countries – a case study of ten research centers in Eastern and Southern Africa

Documenti analoghi

• Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda.
  di: Yunia Mayanja, et al.
  Pubblicazione: (2023-01-01)
• 44 Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya
  di: B.A. Nyaoke, et al.
  Pubblicazione: (2016-07-01)
• Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial.
  di: Juliet Mpendo, et al.
  Pubblicazione: (2020-01-01)
• Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
  di: Borna A Nyaoke, et al.
  Pubblicazione: (2017-01-01)
• A mixed-methods assessment of understanding (AoU) tool for AIDS vaccine trials in sub-Saharan Africa: results from a pilot study
  di: Lindegger G, et al.
  Pubblicazione: (2012-09-01)